Health Care/Hospital
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual J.P. Morgan Healthcare Conference being held in Sa...
2026-01-08 19:00
14355
From Quantified Meditation to Bio-Computing, All Here Launches the Bio-Intelligence Initiative
GENEVA, Jan. 8, 2026 /PRNewswire/ -- All Here announces the launch of the Bio-Intelligence Initiative, the world's first research program exploring how deep meditative states of stability and silence of Mind give rise to measurable neural patterns, and how these complex neural signatures may insp...
2026-01-08 18:48
12707
Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced thatChina's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and Dexmethylphenidate Hydrochloride Capsules (Aizhida) f...
2026-01-08 17:58
11101
Cigna Healthcare Hong Kong Launches Critical Illness Plan to Enhance Health and Financial Protection for Customers
Comprehensive coverage for every stage of the health journey, plus a welcome offer supporting mental health HONG KONG, Jan. 8, 2026 /PRNewswire/ -- Cigna Healthcare Hong Kong today announced the launch of theCigna Healthcare VitalGuard Critical Illness PlanTM (the "Plan"), expanding its medical ...
2026-01-08 17:13
12049
Stay Fit, Stay Well -- The Fitness Industry Is Surging Worldwide
TaiSPO 2026 Pre-registration is Open TAIPEI, Jan. 8, 2026 /PRNewswire/ -- TaiSPO, Taiwan's Sports and Fitness Exhibition, will take place from March 25–28 at Taipei Nangang Exhibition Center Hall 2. Continuing the spirit of "Stay Fit, Stay Well," the event brings key players from the sports, fit...
2026-01-08 12:39
11198
STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy
SEOUL, South Korea, Jan. 8, 2026 /PRNewswire/ -- STARMED, a pioneer in innovative minimally invasive treatment solutions, has announced a comprehensive rebranding. Now in its seventeenth year of operation, the company is formally transitioning from a Radiofrequency Ablation (RFA) specialist into ...
2026-01-08 10:41
13213
Sky Labs Secures CE-MDR for 'CART PLATFORM,' Accelerating Its Global Market Entry
- 'CART,' the blood pressure ring, recognized in Europe for its advanced vital sign monitoring technology - Targeting the global healthcare market beyond Europe through CE-MDR certification SEOUL, South Korea, Jan. 8, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 8th th...
2026-01-08 09:15
7529
Kolmar Korea Wins CES 2026 Best of Innovation Award in Beauty Tech, a Global First for the Cosmetics Industry
* Proving global competitiveness in beauty tech by capturing the CES "Best of
Innovation Award"
* AI-powered 'Scar Beauty Device' earns double honors in Beauty Tech and
Digital Health categories LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- Kolmar Korea
2026-01-07 21:30
9891
iSMART Developments Ltd Announces Strategic Partnership with L'Oréal Groupe
LONDON, Jan. 7, 2026 /PRNewswire/ -- UK-based skincare, aesthetic and medical device innovator iSMART Developments has announced a strategic partnership with L'Oréal Groupe, marking a significant milestone in the company's long-term growth and leadership within the professional grade light therap...
2026-01-07 17:52
6762
'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week
PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San Francisco Marriott Marquis, with both in-person and v...
2026-01-06 21:30
6445
Healthcare Holding Schweiz Acquires Stake in Medddbase International
Healthcare Holding Schweiz AG, a leading service provider and distributor of medical technology inSwitzerland, expands its portfolio through the acquisition of a majority stake in Medddbase International AG, which includes Medddbase Schweiz AG and Medddbase Deutschland GmbH. Healthcare Holding Sc...
2026-01-06 19:19
8334
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
Anticipated advancements in weight loss, diabetes, oncology, rare conditions
and protein degraders poised to reshape patient care
LONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT
2026-01-06 16:21
7017
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
SINGAPORE, Jan. 6, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP service...
2026-01-06 12:03
9401
Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced thatIan Woo, President and Chief Fina...
2026-01-06 07:58
12341
BoomerangFX Expands UK and EMEA Operations With New UK Office and Senior Appointments as demand for AI Clinic Co-Pilot AUVIA™ Drives Record Growth in Healthcare
Expansion builds on global offices in Miami, Toronto, London, and Sydney as BoomerangFX advances its mission to become the foundational AI-powered operating platform for private-pay healthcare worldwide. LONDON, Jan. 6, 2026 /PRNewswire/ -- BoomerangFX, a global AI-powered clinic software and ma...
2026-01-06 03:56
5692
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an internally developed integrin beta-6 (ITGB6)-targeted ant...
2026-01-05 20:00
8691
Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio HONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the"Group"), a global wellness group off...
2026-01-05 17:36
6804
Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) in combination wi...
2026-01-05 17:29
14078
GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application...
2026-01-05 12:07
11435
C&R Research, the 'K-Clinical Hub', Strengthens Partnerships in Indonesia
Accelerating Indonesia Collaboration through Global Clinical Capabilities SEOUL, South Korea, Jan. 5, 2026 /PRNewswire/ -- C&R Research, founded in 1997 as Korea's first full-service Contract Research Organization (CRO), has played a pivotal role in advancing the Korean clinical trial industry an...
2026-01-05 10:00
8637
Week's Top Stories
Most Reposted
Digital Identity Co. Modernizes Thailand Immigration Bureau Services with AWS
[Picked up by 314 media titles]
2026-05-28 15:06The Philippines Sets a New Standard in Muslim-Friendly Tourism
[Picked up by 290 media titles]
2026-05-26 10:30
Asian Society of Cardiovascular Imaging and Philips sign MOU to strengthen imaging capabilities across Asia Pacific
[Picked up by 289 media titles]
2026-05-28 17:34
ASEAN Business Advisory Council (ASEAN-BAC) and AVPN Establish Regional Platform to Strengthen Corporate Social Investment and Cross-Sector Collaboration Across Southeast Asia
[Picked up by 288 media titles]
2026-05-28 10:06Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
[Picked up by 287 media titles]
2026-05-27 09:16
Most Read
/DISREGARD RELEASE: Yangzhou Home Ka Crafts Co., Ltd./
2026-05-29 09:19
6302
ISDN's IDI Dynamics debuts high-speed laser marker for semiconductor assembly and test (OSAT)
2026-05-26 08:40
5317
Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
2026-05-27 09:16
5160
NYSE Content Update: Mastercard Celebrates Two Decades as NYSE-Listed Company
2026-05-26 21:04
5099
